Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Melanoma or Skin Cancer Drug Pipeline Report'
Title Publication Date Price Relevance
Pipeline Insight: Cancer Overview
Gastrointestinal, Skin, Sarcomas
 Jan 2009 £7,210 100%
Melanoma Drug Pipeline Update 2011 Feb 2011 £1,245 89%
Melanoma Drug Pipeline Update 2009 Jan 2009 £1,245 88%
Stakeholder Opinions: Cancer Cachexia - Higher profile needed to unlock market potential of neglected syndrome Jan 2009 £2,405 83%
Commercializing Cancer Vaccines
A Decision Support Tool for Optimizing the Pipeline
 Oct 2010 £1,620 80%
World Market for Psychotherapeutic Drugs, The Jan 2007 £2,215 80%
Worldwide Market for Pediatric Drugs; The
2nd Edition
 Nov 2005 £2,215 79%
Market for Prescription Dermatological Drugs, 7th Edition, The Apr 2010 £2,465 79%
World Market for Prescription Gastrointestinal Drugs, The Jul 2006 £2,215 79%
World Market for Prescription Respiratory Drugs, The Oct 2006 £2,215 79%
World Market for Prescription Orthopedic Drugs, The Oct 2006 £2,215 79%
Cancer Vaccines
Market Forecasts, New Developments and Pipeline Analysis
 Nov 2008 £2,525 79%
World Market for Prescription Generic Drugs; The
5th Edition
 Apr 2006 £2,215 79%
World Market for Pain Management Drugs and Devices
2nd Edition
 Dec 2006 £2,215 78%
Commercializing Peptides in Cancer
The Faster Route to Consider Your Options and Position of Others
 Nov 2011 £2,035 77%
Cancer Vaccines
Aim and Shoot
 May 2008 £1,620 77%
The Global Competitive Landscape of Antibody Drug Development in Cancer
The Faster Route to Consider Your Options and Position of Others
 Sep 2011 £2,035 72%
RNAi
Technologies, Markets and Companies
 Jan 2012 £2,590 67%
TGF-R Agonists and Antagonists
Competitor Analysis
 Nov 2009 £165 66%
Cancer Therapies: Technologies and Global Markets Jan 2008 £3,065 63%
Biomarkers (2 parts)
Technologies, Markets and Companies
 Jan 2012 £3,240 56%